Fig. 6

Anti-tumour activity of oral paclitaxel on tumour tissue in-vivo. (A) Representative images of TUNEL staining in tumour tissues obtained from the xenograft model. (B) Representative images of immunohistochemical staining using an anti-CD31 antibody in tumour tissues obtained from the xenograft model. Quantification of the immunohistochemistry assay was counted in six random fields per group. (C) The collected tumour tissues were subjected to western blot analysis for the evaluation of the expression level of cyclin-D1. Data are expressed as mean ± standard deviation. Statistically significant differences in relation to control are indicated by ‘**’. **p < 0.01